Minerva Surgical, Inc. (UTRS) Q3 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

The conference will begin shortly. To raise your hand during Q&A, you can dial star 1 1. Good day and welcome to Minerva's third quarter 2022 earnings call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session, and instructions will be given at that time. As a reminder, this call may be recorded. I would like to turn the call over to Caroline Corner, Investor Relations. You may begin. Thank you, Operator. Welcome to Minerva's third quarter 2022 earnings call. Joining me on today's call are Dave Clapper, President and Chief Executive Officer, and Jill Young, Chief Financial Officer. This call will provide forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the markets in which Minerva Surgical operates, trends and expectations for Minerva's products and technology, trends and demand for Minerva's products, Minerva's expected financial performance, expenses, and position in the markets, an outlook for fiscal year 2022, and the impact of COVID-19 and its variants on Minerva's operation and Minerva's customers' operations. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance, or achievements to differ materially from any results, performance, or achievements expressed or implied by the forward-looking statements. Please review Minerva's most recent filings with the SEC, particularly the risk factors described in Minerva's quarterly report on Form 10-Q for the quarter ended September 30...